Supernus Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from diseases of the central nervous system (CNS).
01-27-2010 Supernus Announces Positive Results from Phase IIa Clinical Trial for SPN 810 in Children with ADHD and Serious Conduct Problems
Up to 55% Reduction in Key Efficacy Measure for a Novel Therapy read more...
